WuXi PharmaTech Passes EMEA Inspection of Its GMP Manufacturing and Analytical Testing Facilities in Shanghai

SHANGHAI, China, Feb. 23 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX),

a leading pharmaceutical, biotechnology and medical device research and

development outsourcing company with operations in China and the United States,

announced today that it received the formal certificate of GMP complia

http://digg.com/u1O8fu